Cargando…
High Incidence of Psychiatric Disorders Associated with Cycloserine Treatment of Multidrug-Resistant Tuberculosis Patients: A Cohort Study in Beijing, China
OBJECTIVE: Cycloserine (CS) is a group B anti-tuberculosis (TB) drug endorsed by the World Health Organization (WHO) for the treatment of drug-resistant (DR)-TB. Despite CS widespread acceptance and known efficacy, the high potential of drug-associated psychiatric disorders is a major concern to mul...
Autores principales: | Pang, Yu, Liu, Rongmei, Song, Yanhua, Lv, Zizheng, Gao, Mengqiu, Nie, Lihui, Ge, Qiping, Wu, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289756/ https://www.ncbi.nlm.nih.gov/pubmed/35859910 http://dx.doi.org/10.2147/IDR.S369715 |
Ejemplares similares
-
Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China
por: Li, Yang, et al.
Publicado: (2019) -
Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
por: Tornheim, Jeffrey A., et al.
Publicado: (2022) -
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2021) -
Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China
por: Wang, Jing, et al.
Publicado: (2019) -
Cycloserine-Induced Insomnia and Psychosis in Multidrug-Resistant Pulmonary Tuberculosis - A Case Report
por: Yadav, Sankalp
Publicado: (2022)